Literature DB >> 10861213

Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.

M H Baumann1, J Kallijärvi, H Lankinen, C Soto, M Haltia.   

Abstract

Inheritance of the apolipoprotein E (apoE) epsilon 4 allele is a risk factor for late-onset Alzheimer's disease (AD). Biochemically apoE is present in AD plaques and neurofibrillary tangles of the AD brain. There is a high avidity and specific binding of apoE and the amyloid beta-peptide (A beta). In addition to AD apoE is also present in many other cerebral and systemic amyloidoses, Down's syndrome and prion diseases but the pathophysiological basis for its presence is still unknown. In the present study we have compared the interaction of apoE with A beta, the gelsolin-derived amyloid fragment AGel(183-210) and the amyloidogenic prion fragments PrP(109-122) and PrP(109-141). We show that, similar to A beta, also AGel and PrP fragments can form a complex with apoE, and that the interaction between apoE and the amyloidogenic protein fragments is mediated through the same binding site on apoE. We also show that apoE increases the thioflavin-T fluorescence of PrP and AGel and that apoE influences the content of beta-sheet conformation of these amyloidogenic fragments. Our results indicate that amyloids and amyloidogenic prion fragments share a similar structural motif, which is recognized by apoE, possibly through a single binding site, and that this motif is also responsible for the amyloidogenicity of these fragments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861213      PMCID: PMC1221122          DOI: 10.1042/0264-6021:3490077

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro.

Authors:  A Gustavsson; U Engström; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

2.  Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

Authors:  K R Bales; T Verina; R C Dodel; Y Du; L Altstiel; M Bender; P Hyslop; E M Johnstone; S P Little; D J Cummins; P Piccardo; B Ghetti; S M Paul
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

3.  Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein.

Authors:  G G Glenner; E D Eanes; C A Wiley
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

4.  Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.

Authors:  P Westermark; U Engström; K H Johnson; G T Westermark; C Betsholtz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

6.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

7.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

8.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

9.  Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain.

Authors:  D J Kwiatkowski; T P Stossel; S H Orkin; J E Mole; H R Colten; H L Yin
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

10.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

View more
  5 in total

1.  Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Authors:  Roger A Moore; Andrew G Timmes; Phillip A Wilmarth; David Safronetz; Suzette A Priola
Journal:  Proteomics       Date:  2011-09-07       Impact factor: 3.984

2.  Prion Efficiently Replicates in α-Synuclein Knockout Mice.

Authors:  Edoardo Bistaffa; Martina Rossi; Chiara Maria Giulia De Luca; Federico Cazzaniga; Olga Carletta; Ilaria Campagnani; Fabrizio Tagliavini; Giuseppe Legname; Giorgio Giaccone; Fabio Moda
Journal:  Mol Neurobiol       Date:  2019-04-30       Impact factor: 5.590

Review 3.  Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.

Authors:  Marie-Isabel Aguilar; David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  Cellular aspects of prion replication in vitro.

Authors:  Andrea Grassmann; Hanna Wolf; Julia Hofmann; James Graham; Ina Vorberg
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

5.  Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.

Authors:  Laura E Donovan; Eric B Dammer; Duc M Duong; John J Hanfelt; Allan I Levey; Nicholas T Seyfried; James J Lah
Journal:  Alzheimers Res Ther       Date:  2013-06-13       Impact factor: 6.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.